Breast Cancer Episode 12: Antibody-drug conjugates: the evolving field of targeted chemotherapy in breast cancer 21 December 2023
GI Episode 5: The SUNLIGHT trial: new standard third line therapy for metastatic colorectal cancer 20 December 2023
GI Episode 4: Zolbetuximab: a new opportunity in the treatment of CLDN18.2 positive metastatic gastric cancer patients 13 December 2023
GI Episode 3: Pembrolizumab with chemotherapy in first line treatment of metastatic gastric cancer 6 December 2023
Breast Cancer Episode 11: Capecitabine: optimisation of dosing strategy and the use of topical diclofenac in prevention of hand-foot syndrome 30 November 2023
GI Episode 2: LEAP 017 – study: efficacy and safety of lenvatinib + pembrolizumab versus standard-of-care in previously treated mCRC 29 November 2023
Breast Cancer Episode 10: Meta analysis of ovarian function suppression in early luminal breast cancer 23 November 2023
GI Episode 1: The NAPOLI-3 study, the benefit of triplet therapy in first-line treatment of metastatic pancreatic ductal adenocarcinoma 22 November 2023
Breast Cancer Episode 8: The DATA trial and the GIM trial: how to decide on extended endocrine therapy in Postmenopausal Breast Cancer Patients 9 November 2023
